Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review

[1]  D. Levy,et al.  Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. , 2006, Archives of internal medicine.

[2]  Chris Jones,et al.  Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  N. Powe,et al.  Identification and referral of patients with progressive CKD: a national study. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  M. Schnitzler,et al.  Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. , 2006, Journal of the American Society of Nephrology : JASN.

[5]  D. M. Large,et al.  The joint diabetic-renal clinic in clinical practice: 10 years of data from a District General Hospital. , 2006, QJM : monthly journal of the Association of Physicians.

[6]  C. Zoccali,et al.  Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. , 2006, Kidney international.

[7]  J. Avorn,et al.  Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  P. Zamboli,et al.  Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study. , 2005, Seminars in nephrology.

[9]  Caren Rose,et al.  Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  Oliver Lenz,et al.  Barriers to successful care for chronic kidney disease , 2005, BMC nephrology.

[11]  A. Collins,et al.  General medical care among patients with chronic kidney disease: opportunities for improving outcomes. , 2005, Journal of the American Society of Nephrology : JASN.

[12]  Katrin Uhlig,et al.  Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[13]  T. Casale,et al.  Incidence and characteristics of angioedema associated with enalapril. , 2005, Archives of internal medicine.

[14]  I. Os,et al.  Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate‐to‐severe reductions in renal function , 2005, Blood pressure.

[15]  P. Zamboli,et al.  Management of hypertension in patients with CKD: differences between primary and tertiary care settings. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  H. Kramer,et al.  Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study , 2005, BMC nephrology.

[17]  R. Wolfe,et al.  Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  Tom Chan,et al.  Identifying patients with chronic kidney disease from general practice computer records. , 2005, Family practice.

[19]  G. Beck,et al.  The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study , 2005, Annals of Internal Medicine.

[20]  B. Murray,et al.  Delivery of Predialysis Care in an Academic Referral Nephrology Practice , 2005, Renal failure.

[21]  M. Tonelli,et al.  The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. , 2004, Journal of the American College of Cardiology.

[22]  R. Lafayette,et al.  Examining chronic kidney disease management in a single center. , 2004, Clinical nephrology.

[23]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[24]  R. Ozaki,et al.  Effect of Angiotensin-Converting Enzyme Inhibition on Survival in 3773 Chinese Type 2 Diabetic Patients , 2004, Hypertension.

[25]  Jennifer Y. Liu,et al.  Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes , 2004, Journal of General Internal Medicine.

[26]  P. Armstrong,et al.  Renal Insufficiency and Heart Failure: Prognostic and Therapeutic Implications From a Prospective Cohort Study , 2004, Circulation.

[27]  S. Rajagopalan,et al.  RENAL RESEARCH INSTITUTE SYMPOSIUM: The Longitudinal Chronic Kidney Disease Study: A Prospective Cohort Study of Predialysis Renal Failure , 2003, Seminars in dialysis.

[28]  Keith C. Norris,et al.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  Christopher H Schmid,et al.  Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.

[30]  Jerry Avorn,et al.  The nephrologist's role in the management of calcium-phosphorus metabolism in patients with chronic kidney disease. , 2003, Kidney international.

[31]  Wing W. Chan,et al.  Examination of Resource Use and Clinical Interventions Associated With Chronic Kidney Disease in a Managed Care Population , 2003, Journal of managed care pharmacy : JMCP.

[32]  B. Starfield,et al.  Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. , 2002, Archives of internal medicine.

[33]  I. D. de Boer,et al.  The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. , 2002, Journal of the American Society of Nephrology : JASN.

[34]  A. Israni,et al.  Management of Chronic Kidney Disease in an Academic Primary Care Clinic , 2002, American Journal of Nephrology.

[35]  J. Avorn,et al.  Nephrologist care and mortality in patients with chronic renal insufficiency. , 2002, Archives of internal medicine.

[36]  Nancy Fink,et al.  The Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality , 2002, Annals of Internal Medicine.

[37]  S. Wade,et al.  Health care resource utilization and the impact of anemia management in patients with chronic kidney disease. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  A. Levin,et al.  Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  D. Hirsch,et al.  Quality of prereferral care in patients with chronic renal insufficiency. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  H. Tighiouart,et al.  Health care utilization among patients with chronic kidney disease. , 2002, Kidney international.

[41]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[42]  J Singer,et al.  Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  G J Kuperman,et al.  Blood pressure and angiotensin converting enzyme inhibitor use in hypertensive patients with chronic renal insufficiency. , 2001, American journal of hypertension.

[44]  A. Nissenson,et al.  Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. , 2001, Journal of the American Society of Nephrology : JASN.

[45]  A. Kausz,et al.  Management of patients with chronic renal insufficiency in the Northeastern United States. , 2001, Journal of the American Society of Nephrology : JASN.

[46]  A. Levin,et al.  Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  Giuseppe Remuzzi,et al.  Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria , 1999, The Lancet.

[48]  B. Pereira,et al.  Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[49]  T. Hostetter,et al.  CKD risk factors reported by primary care physicians: do guidelines make a difference? , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[50]  P. Roderick,et al.  An evaluation of a shared primary and secondary care nephrology service for managing patients with moderate to advanced CKD. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[51]  T. Gilmer,et al.  Predictors of health care costs in adults with diabetes. , 2005, Diabetes care.

[52]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[53]  K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[54]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.